Palvella Set for Goldman Conference Amid Rare Disease Push
WAYNE, PA — Palvella Therapeutics (Nasdaq: PVLA) will present its development strategy to investors this week as the clinical-stage biotechnology company advances a pipeline of experimental treatments targeting rare dermatological …
Palvella Set for Goldman Conference Amid Rare Disease Push Read More